antibodi
sarscoronaviru
sarscov
specif
b
cell
epitop
might
recogn
pathogen
interrupt
adher
penetr
host
cell
henc
epitop
could
use
diagnosi
vaccin
constitu
use
phagedisplay
peptid
librari
screen
method
purifi
fab
fragment
immunoglobulin
g
igg
fab
normal
human
sera
convalesc
sera
sarscovinfect
patient
target
b
cell
epitop
sarscov
spike
glycoprotein
protein
membran
protein
protein
screen
bioinformat
tool
use
analyz
epitop
four
epitopebas
protein
dodecapeptid
correspond
predomin
epitop
chosen
synthesi
antigen
specif
immunogen
studi
vitro
vivo
flow
cytometri
elispot
analysi
lymphocyt
well
serolog
analysi
antibodi
show
peptid
could
trigger
rapid
highli
effect
rel
safe
immun
respons
balbc
mice
find
might
aid
develop
sar
diagnost
vaccin
moreov
role
protein
import
surfac
antigen
confirm
select
sarscoronavirusspecif
b
cell
epitop
phage
peptid
librari
screen
evalu
immunolog
effect
epitopebas
peptid
mice
sever
acut
respiratori
syndrom
sar
new
viru
infecti
diseas
high
fatal
rate
spread
countri
novel
coronaviru
design
sarscoronaviru
sarscov
respons
seriou
infecti
diseas
drosten
et
al
fouchier
et
al
ksiazek
et
al
peiri
et
al
poutanen
et
al
although
global
outbreak
sar
control
viru
isol
wild
anim
layan
palm
civet
raccoon
dog
actual
natur
reservoir
sarscov
still
unknown
reemerg
futur
remain
possibl
better
prevent
futur
sar
epidem
protect
vaccin
reliabl
diagnost
reagent
must
develop
control
lifethreaten
diseas
b
cell
epitop
defin
region
surfac
nativ
antigen
recogn
bind
b
cell
receptor
specif
antibodi
epitop
focu
immunolog
research
well
target
develop
vaccin
diagnost
reagent
vanniasinkam
et
al
viud
et
al
therefor
present
studi
screen
identifi
specif
b
cell
epitop
sarscov
use
phagedisplay
peptid
librari
fab
fragment
antisarscov
immunoglobulin
g
igg
normal
human
igg
target
improv
biopan
procedur
immun
respons
induc
four
epitopebas
peptid
also
evalu
anim
experi
product
serum
treatment
antisarscov
igg
fab
kda
shown
elisa
western
blot
bind
specif
sarscov
antigen
immunoscreen
two
igg
fab
target
enrich
phage
popul
bind
antisarscov
igg
fab
select
phage
clone
immunoposit
clone
signific
enhanc
bind
activ
sarscovspecif
antibodi
normal
human
serum
fig
homolog
peptid
sequenc
seri
epitop
insert
target
phage
primari
sequenc
structur
protein
sarscov
compar
tabl
seen
tabl
doubl
select
process
result
differ
peptid
could
divid
three
group
nine
peptid
homolog
nine
differ
region
sarscov
protein
two
peptid
homolog
two
region
protein
one
peptid
without
homolog
sarscov
structur
protein
peptid
show
strike
resembl
peptid
sequenc
shvplatsrtla
contain
six
match
protein
sequenc
isol
shvplatsrtla
sequenc
five
time
group
tabl
major
epitop
isol
screen
gener
evalu
epitop
bioinform
softwar
four
predomin
epitop
sarscov
protein
select
correspond
epitopebas
peptid
ateksnvvrgwv
ntrnidatstgn
pfspdgkpctpp
hegkayfpregv
accord
synthes
prove
phageborn
peptid
real
epitop
sarscov
peptid
competitiveinhibit
assay
perform
determin
whether
synthet
peptid
correspond
phage
clone
compet
antibodybind
site
competitiveinhibit
assay
peptid
dosedepend
block
bind
correspond
phage
clone
target
fig
moreov
four
peptid
react
sarscovspecif
serum
antibodi
crossreact
sera
healthi
donor
sera
fig
antibodi
respons
elicit
epitopebas
peptid
determin
use
elisa
titer
antisera
challeng
mice
shown
fig
everi
epitopebas
peptid
stimul
antibodi
product
even
primari
immun
second
immun
substanti
increas
antibodi
titer
within
week
specif
antibodi
still
detect
day
high
titer
suggest
strong
rel
longterm
humor
immun
respons
induc
four
b
cell
epitop
antipeptid
antibodi
react
sarscov
antigen
specif
fail
react
antigen
fig
effect
peptid
splenic
lymphocyt
subset
isol
challeng
mice
analyz
use
twocolor
flow
cytometri
day
day
primari
immun
rel
number
b
cell
increas
significantli
cell
decreas
rel
control
group
level
tabl
although
number
cell
cell
decreas
simultan
decreas
greater
latter
former
consequ
fig
identif
specif
phage
clone
reactiv
antisarscov
serum
elisa
repres
elisa
result
react
differ
phage
clone
select
immunoscreen
patient
serum
mixturenorm
human
serum
mixtur
repres
result
wild
type
phage
neg
control
serum
sampl
four
round
biopan
twice
phage
clone
select
phage
clone
significantli
reactiv
antisarscov
serum
normal
human
serum
b
repres
respect
immun
reactiv
phage
clone
pick
random
first
second
time
phage
clone
carri
neg
control
react
neither
patient
serum
mixtur
normal
human
serum
mixtur
ratio
cell
littl
higher
howev
increas
cell
ratio
similar
control
group
mapimmun
group
except
group
day
suggest
epitopebas
peptid
imbal
immunolog
system
subsequ
activ
cell
cellb
cell
ratio
progress
return
normal
level
group
except
group
low
level
result
demonstr
humor
immun
respons
predomin
rapidli
trigger
epitopebas
peptid
especi
sinc
express
surfac
molecul
lselectin
cell
use
distinguish
memori
cell
high
low
lselectin
monitor
phenotyp
chang
use
threecolor
flow
cytometr
analysi
lymphocyt
epitopebas
peptideimmun
mice
day
third
immun
show
classic
immunolog
memori
phenotyp
high
low
lselectin
fig
reinject
specif
peptid
continu
upregul
level
alway
lower
pb
control
slight
downregul
cell
stimul
day
observ
level
return
day
subsequ
fluctuat
remain
higher
pb
control
continu
upregul
cell
challeng
mice
frequenc
cell
singl
cell
level
determin
elispot
assay
shown
fig
day
primari
immun
number
cell
spleen
increas
significantli
spot
cell
fourteen
day
primari
immun
number
cell
remain
elev
spot
cell
moreov
number
cell
mice
boost
peptid
increas
wherea
number
cell
remain
low
level
spot
cell
data
demonstr
four
b
cell
epitop
effect
enhanc
humor
immun
cellular
immun
result
antigenspecif
lymphocyt
cell
prolifer
assay
indic
map
dosedepend
stimul
prolif
respons
effect
induc
lymphocyt
prolifer
tabl
splenic
lymphocyt
mice
day
still
exhibit
signific
prolif
respons
specif
antigen
demonstr
four
epitopebas
peptid
induc
longterm
immun
respons
data
shown
phagedisplay
peptid
librari
wide
varieti
use
cortes
et
al
petersen
et
al
pereboeva
et
al
note
screen
consist
four
round
pan
affinitypurifi
target
antibodi
number
either
side
sequenc
denot
amino
acid
sequenc
number
letter
bold
denot
match
phage
sequenc
sarscov
sequenc
italic
bold
letter
denot
conserv
substitut
number
right
indic
number
time
correspond
peptid
isol
number
parenthesi
refer
screen
peptid
isol
ie
first
screen
second
screen
correspond
phage
clone
chosen
competitiveinhibit
assay
wu
et
al
techniqu
use
mostli
screen
monoclon
antibodi
littl
screen
purifi
polyclon
antibodi
prepar
folgori
et
al
kay
et
al
robert
et
al
liu
et
al
success
screen
polyclon
antisera
use
techniqu
probabl
newli
improv
biopan
adopt
target
chose
antisarscov
serum
contain
mostli
sarscov
antibodi
antibodi
pathogen
convent
biopan
process
antisarscov
sera
target
nonspecif
phage
clone
bind
sarscovspecif
immunoglobulin
instead
antibodi
specif
pathogen
might
amplifi
addit
research
report
nonspecif
clone
bind
target
plastic
plate
could
also
chosen
sever
convent
biopan
procedur
adey
et
al
improv
biopan
procedur
avoid
possibl
ensur
specif
select
antisarscov
igg
fab
simplest
fragment
specif
antibodi
facilit
antigen
specif
biopan
procedur
repeat
fourround
biopan
abl
select
eleven
sarscov
epitop
form
subset
linear
epitop
moreov
found
anoth
peptid
sequenc
display
immunoposit
phage
clone
without
homolog
primari
sequenc
sarscov
protein
structur
epitop
recogn
bound
b
cell
receptor
bcr
shown
linear
spatial
classic
experi
michael
sela
year
ago
sela
phagedisplay
peptid
librari
gener
shotgun
clone
random
oligonucleotid
end
either
piii
pviii
gene
filament
phage
peptid
encod
insert
nucleotid
display
phage
surfac
independ
spatial
structur
cwirla
et
al
luzzago
et
al
nonhomolog
peptid
sequenc
might
reflect
presenc
discontinu
epitop
sarscov
addit
sarscov
antigen
crossreact
virus
nonhomolog
peptid
sequenc
might
also
epitop
differ
viru
certainli
find
must
studi
among
linear
epitop
nine
consid
protein
epitop
five
epitop
protein
four
protein
two
protein
epitop
decrement
tendenc
number
epitop
protein
protein
protein
connect
locat
protein
virion
epitop
locat
region
predict
epitop
known
exist
minor
epitop
locat
amino
acid
away
predict
epitop
region
yuxian
et
al
yanbo
et
al
yanbo
et
al
two
locat
region
viru
bind
host
cell
receptor
aceii
protein
respons
induc
host
immun
respons
viru
neutral
antibodi
holm
navasmartin
weiss
neutral
antibodi
protect
mice
primat
sarscov
infect
bisht
et
al
buchholz
et
al
bukreyev
et
al
gao
et
al
yang
et
al
research
provid
indirect
proof
protein
sarscov
import
surfac
antigen
stimulu
host
immun
respons
protein
coronavirus
immunogen
enjuan
et
al
virion
structur
sarscov
b
cell
epitop
characterist
b
cell
epitop
result
suggest
protein
sarscov
also
play
import
role
induc
antibodi
product
sought
character
antigen
immunogen
sarscov
epitopebas
peptid
facilit
develop
effect
sar
diagnost
vaccin
recent
studi
demonstr
sarscov
coronavirus
antigen
crossreact
ksiazek
et
al
woo
et
al
four
protein
epitopebas
peptid
proven
sarscov
specif
antibodi
mice
induc
also
react
specif
sarscov
though
studi
specif
sensit
need
epitop
consid
potenti
immunoreact
epitop
diagnost
reagent
immunolog
effect
epitopebas
peptid
studi
lymphocyt
prolifer
assay
show
four
epitopebas
peptid
stimul
immun
system
secret
b
cell
growth
differenti
factor
might
reflect
state
activ
prolifer
b
cell
transit
antibodyproduc
plasma
cell
increas
dramat
greater
number
cell
number
cell
immun
epitopebas
peptid
confirm
humor
immun
predomin
epitop
select
real
b
cell
epitop
specif
antibodi
induc
four
epitop
persist
least
week
confirm
monitor
igg
titer
although
specif
igg
could
detect
primari
immun
persist
high
titer
igg
requir
revaccin
indic
involv
humor
immun
memori
within
week
revaccin
b
cell
number
peak
indirectli
prove
antigenspecif
memori
b
cell
could
induc
epitop
peptid
suggest
lymphocyt
mice
immun
four
differ
peptid
day
day
day
primari
immun
n
result
mean
sd
p
valu
compar
control
group
b
p
valu
compar
control
group
fig
threecolor
flow
cytometr
analysi
surfac
marker
express
cell
isol
spleen
immun
mice
day
day
third
immun
gate
set
cell
experi
repeat
three
time
overal
result
valu
within
box
indic
rel
cell
number
epitop
potenti
develop
sar
vaccin
induc
rapid
increas
number
cell
enhanc
humor
immun
indic
potenti
use
emerg
prophylaxi
sar
induc
rel
slow
persist
increas
enhanc
humor
immun
indic
potenti
use
longterm
prophylaxi
sar
sinc
activ
th
cell
also
need
effect
humor
immun
th
cell
activ
rapidli
help
immun
memori
mice
bradley
et
al
yin
et
al
budd
et
al
butterfield
et
al
use
distinguish
naiv
memori
cell
naiv
activ
cell
gerberick
et
al
studi
epitopebas
peptideimmun
mice
classic
phenotyp
immunolog
memori
high
lselectin
low
present
surfac
lymphocyt
third
immun
day
suggest
epitopebas
peptid
could
enhanc
memori
cell
respons
therebi
increas
immun
surveil
defens
capac
carri
auxiliari
function
specif
antigen
reappear
excess
depress
immun
respons
result
immunolog
derang
advers
affect
bodi
import
know
whether
epitop
keep
steadi
state
immun
system
especi
use
constitu
vaccin
monitor
chang
lymphocyt
subset
number
splenic
lymphocyt
happili
safeti
four
b
cell
epitop
confirm
studi
provid
sever
sarscov
epitop
along
immunolog
characterist
four
epitop
abil
induc
rapid
strong
longterm
humor
immun
also
safe
effect
least
mice
therefor
four
epitop
might
potenti
use
constitu
sar
vaccin
moreov
limit
studi
antigen
specif
four
epitop
suggest
potenti
use
diagnost
biomark
addit
protein
import
surfac
antigen
sarscov
confirm
result
immunoselect
b
cell
epitop
antisarscov
serum
sampl
collect
convalescentphas
sar
patient
diagnost
criteria
sarscov
infect
follow
clinic
descript
sar
releas
world
health
organ
within
month
recuper
test
posit
sarscov
antibodi
use
commerci
avail
enzymelink
immunosorb
assay
elisa
kit
huada
compani
peke
china
antibodi
titer
vari
normal
human
serum
sampl
sarscov
seroneg
pool
seven
blood
donor
standard
strain
human
coronavirus
specif
antisera
murin
origin
obtain
guangdong
center
diseas
control
cdc
four
epitopebas
dodecapeptid
synthes
form
eightbranch
multipl
antigen
peptid
map
construct
puriti
huacheng
compani
xian
china
coincid
actual
molecular
mass
theoret
molecular
mass
confirm
mass
spectrographi
analysi
femal
balbc
mice
purchas
centr
experiment
anim
sun
yatsen
univers
guangzhou
china
anim
experi
ethic
committe
sun
yatsen
univers
approv
protocol
experi
perform
studi
anim
handl
accord
guidelin
chines
council
anim
care
immunoglobulin
g
igg
convalesc
normal
human
serum
purifi
respect
use
affin
column
protein
sepharos
dingguo
compani
peke
china
fab
fragment
igg
igg
fab
prepar
digest
intact
igg
caroid
digest
rechromatograph
use
anoth
protein
sepharos
column
puriti
target
check
sdspage
antigen
determin
use
elisa
western
blot
human
igg
igg
fab
sigma
chemic
st
loui
mo
usa
use
refer
horseradish
peroxidas
hrp
label
goat
antihuman
igg
igg
fab
sigma
use
detector
antibodi
identif
bind
activ
sarscovantigen
target
molecul
determin
use
elisa
enrich
phage
clone
specif
antisarscov
igg
fab
improv
convent
biopan
procedur
first
round
biopan
perform
immobil
antisar
fa
control
bal
bc
mice
inject
twice
epitopebas
peptid
form
map
construct
mice
receiv
pb
cfa
serv
neg
control
day
final
immun
splenocyt
lymphocyt
prolifer
assay
pool
immun
mice
b
valu
one
repres
experi
five
perform
present
mean
stimul
index
quadrupl
well
sd
cov
igg
fab
ensur
phage
clone
bind
includ
pool
first
screen
word
phage
origin
librari
new
england
biolab
ipswich
usa
immunoscreen
antisarscov
igg
fab
h
room
temperatur
unbound
phage
remov
wash
bound
phage
elut
glycinehcl
ph
mg
ml
bsa
neutral
trishcl
ph
titrat
lbiptgxgal
promega
madison
wi
usa
plate
amplif
firstround
select
phage
immunoscreen
normal
igg
fab
unbound
phage
collect
remov
phage
specif
antisarscov
igg
fab
second
biopan
protocol
third
fourth
immunoscreen
ident
first
round
except
phage
particl
use
input
tween
concentr
increas
wash
vv
four
round
biopan
repeat
thirti
blue
plaqu
fourthround
titrat
plate
pick
random
amplifi
host
bacteria
e
coli
precipit
polyethylen
glycol
peg
nacl
elisa
perform
plate
coat
respect
ml
antisarscov
serum
mixtur
normal
human
serum
mixtur
block
phage
particl
clone
per
well
incub
h
plate
wash
least
six
time
tbst
hrpconjug
antibodi
pharmacia
biotech
piscataway
nj
usa
dilut
bsa
block
buffer
ad
plate
incub
h
wash
react
substrat
acid
abt
color
develop
min
dark
absorb
nm
measur
micropl
reader
multiskan
thermo
labsystem
shanghai
china
equal
amount
wild
type
phage
use
neg
control
simultan
immunoposit
phage
clone
preserv
target
clone
studi
singlestrand
dna
prepar
target
clone
templat
giii
primer
use
sequenc
sequenc
dna
insert
target
phage
clone
translat
amino
acid
sequenc
compar
structur
protein
sarscov
etc
retriev
genebank
site
wwwncbinlmnih
gov
use
standard
proteinprotein
blast
clustal
w
multipl
sequenc
align
public
softwar
analyz
sever
properti
epitop
includ
hydrophil
antigen
access
flexibl
polar
secondari
structur
chose
four
predomin
epitop
dodecapeptid
synthes
studi
competitiveinhibit
assay
competitiveinhibit
experi
coat
antisarscov
serum
block
wash
perform
differ
amount
four
synthet
peptid
correspond
phage
clone
ad
simultan
incub
h
step
follow
absorb
measur
inhibit
percentag
calcul
follow
inhibit
od
without
competitor
od
competitor
od
without
competitor
bind
assay
assess
specif
epitopebas
peptid
abil
bind
normal
human
antisarscov
sera
examin
elisa
antisera
incub
h
elisa
well
coat
ml
epitopebas
peptid
wash
well
incub
correspond
hrpconjug
second
antibodi
h
ophenylenediamin
opd
develop
color
final
optic
densiti
od
valu
nm
measur
monitor
specif
antibodi
titer
cytokin
level
lymphocyt
prolifer
mice
randomli
divid
six
group
one
group
four
peptid
one
pb
control
one
freund
adjuv
fa
control
n
mice
immun
subcutan
peptid
immunogen
presenc
freund
complet
adjuv
boost
freshli
prepar
emuls
immunogen
freund
incomplet
adjuv
interv
gener
immunolog
memori
mice
second
immun
follow
rest
period
studi
cell
recal
respons
mice
immunolog
memori
immun
peptid
without
adjuv
akbar
et
al
third
time
blood
sampl
obtain
later
tail
vein
mice
day
primari
immun
antibodi
titer
measur
use
synthet
peptid
coat
antigen
igg
elisa
viral
suspens
titer
tcid
ml
use
prepar
viru
antigen
antibodi
specif
determin
igg
elisa
reactiv
sera
antigen
sarscov
respect
spleen
cut
piec
care
forc
metal
mesh
flow
cytometr
analysi
splenocyt
suspens
treat
rbc
lysi
buffer
ebiosci
san
diego
ca
usa
lyse
erythrocyt
wash
suspend
concentr
cell
ml
stain
buffer
dpb
ph
nan
calf
serum
enzymelink
immunospot
elispot
lymphocyt
prolifer
assay
lymphocyt
separ
splenocyt
suspens
densiti
gradient
centrifug
suspend
cell
ml
rpmi
lymphocyt
sampl
prepar
use
freshli
fifti
microlit
suspend
lymphocyt
prepar
harvest
respect
twiceimmun
mice
day
first
immun
boost
memori
mice
day
third
immun
incub
panel
antimous
antibodi
surfac
molecul
fluorescein
isothiocyan
fitc
conjug
phycoerythrin
pe
conjug
allophycocyanin
apc
conjug
lselectin
ebiosci
incub
min
dark
cell
wash
three
time
suspend
paraformaldehyd
analyz
use
bd
fac
instrument
becton
dickinson
franklin
lake
nj
usa
antibodyisotyp
control
flow
cytometr
analys
carri
essenti
manner
data
analyz
use
bd
facsdiva
softwar
assess
peptidespecif
cell
use
elispot
techniqu
cell
assess
specif
elispot
kit
accord
manufactur
protocol
ucytech
utrecht
netherland
briefli
lymphocyt
immun
mice
day
primari
immun
incub
correspond
peptid
pha
final
concentr
ml
well
coat
captur
antibodi
antibodi
well
wash
block
proper
incub
co
cell
remov
wash
secret
cytokin
detect
biotinlabel
antimurin
monoclon
antibodi
spot
count
automat
reader
one
hundr
microlit
prepar
lymphocyt
cultur
quadrupl
plate
presenc
correspond
peptid
final
concentr
ml
respect
control
pha
ml
incub
h
supernat
remov
diphenyltetrazolium
bromid
mtt
ml
ad
incub
h
lymphocyt
lyse
dimethylsulfoxid
dmso
room
temperatur
min
develop
color
od
valu
nm
measur
student
test
use
statist
analysi
